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Background: Pediatric rheumatic diseases have a significant impact on children’s quality of life and family
functioning. Disease control and management of the symptoms are important to minimize disability and pain.
Specialist clinical nurses play a key role in supporting medical teams, recognizing poor disease control and the
need for treatment changes, providing a resource to patients on treatment options and access to additional
support and advice, and identifying best practices to achieve optimal outcomes for patients and their families. This
highlights the importance of investigating follow-up telenursing (TN) consultations with experienced, specialist
clinical nurses in rheumatology to provide this support to children and their families.
Methods/Design: This randomized crossover, experimental longitudinal study will compare the effects of standard
care against a novel telenursing consultation on children’s and family outcomes. It will examine children below
16 years old, recently diagnosed with inflammatory rheumatic diseases, who attend the pediatric rheumatology
outpatient clinic of a tertiary referral hospital in western Switzerland, and one of their parents. The telenursing
consultation, at least once a month, by a qualified, experienced, specialist nurse in pediatric rheumatology will
consist of providing affective support, health information, and aid to decision-making. Cox’s Interaction Model of
Client Health Behavior serves as the theoretical framework for this study. The primary outcome measure is satisfaction
and this will be assessed using mixed methods (quantitative and qualitative data). Secondary outcome measures
include disease activity, quality of life, adherence to treatment, use of the telenursing service, and cost. We plan to
enroll 56 children.
Discussion: The telenursing consultation is designed to support parents and children/adolescents during the
course of the disease with regular follow-up. This project is novel because it is based on a theoretical standardized
intervention, yet it allows for individualized care. We expect this trial to confirm the importance of support by a
clinical specialist nurse in improving outcomes for children and adolescents with inflammatory rheumatisms.
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Pediatric rheumatism represents a large group of inflam-
matory and non-inflammatory diseases of the locomotion
system. Most of the children affected by these diseases
present a chronic course and this can have a significant
impact on their quality of life. Rheumatic diseases can
have long-term effects on patients’ lives and may interfere
with their schooling, their later working life, as well as
with family functioning. Over the last decade, the treat-
ment of inflammatory rheumatic diseases has significantly
improved thanks to the use of new biological agents, al-
though their therapeutic benefits can be accompanied by
significant undesirable side effects. These new drugs are
also expensive and thus participate significantly to the
burdens these diseases place on health spending and soci-
ety. To offer high quality care to these children and their
families, it is essential to promote the best possible quality
of life and limit the financial and social costs of pediatric
rheumatic diseases.
According to recent data from the Swiss registry of
pediatric rheumatic diseases, the annual incidence of all
patients seen by the nine national centers was 40.6 new
patients per 100,000 children, with 56.8/100,000 in the
Canton of Vaud (western Switzerland) [1]. Close to two
thirds of these patients (n = 2,120) were diagnosed with
an inflammatory disease. These can be classified into
three groups: juvenile idiopathic arthritis (JIA), connective
tissue diseases (CTD), and other inflammatory diseases
[1]. JIA is the most common childhood inflammatory
rheumatic disease and is an important cause of short- and
long-term disability [2,3]. The typical clinical symptoms of
JIA last for a minimum of 6 weeks and include persistent
swelling of one or more joints, limited range of motion in
the joints, pain during movement, and inflammation that
may last for years until adulthood [4]. Fever, reduced
physical activity, poor appetite, and flu-like symptoms are
also clinical features of patients suffering from JIA [5]. JIA
is a heterogeneous disease comprising seven different cat-
egories, and disease severity varies widely between pa-
tients [6]. Inflammation associated with JIA and other
rheumatic diseases can result in significant chronic pain
[7,8], decreased functional ability [9], impaired physical
development [10], and decreased overall well-being and
quality of life [11,12]. The disease and its associated treat-
ment challenge children and their families daily; children
face altered body image, anxiety from teasing and social
nonacceptance, fears about the course of the disease, and
uncertainty about their future [13]. The PRINTO study
showed significant physical impairment and suboptimal
psychosocial functioning in children with JIA when
compared to healthy matched-controls. In the JIA chil-
dren, physical status was mostly altered by the level of
disability, whereas psychosocial health was more affected
by chronic pain [14,15]. In addition to clinical symptoms,inflammatory rheumatic diseases, like any chronic disease,
have a significant impact on the functioning of the family
as a whole and create significant distress for parents [16].
As Hopia stated, “parental well-being is governed by the
child’s illness. When a child has a chronic illness, the
whole family is ill” (p.191) [17]. Families with chronically
ill children not only have to learn how to adjust to their
child’s needs, but also how to mobilize their resources
to maintain their own health and positive mental im-
ages, and manage their uncertainty, anxiety, and distress
[16,18].
In summary, the consequences of inflammatory rheum-
atic diseases on children and their families are significant.
Up to 75% of these children go on to suffer from symp-
toms or complications related to the disease in adulthood
[19-21]. Long-term follow-up of adults who had suffered
from JIA showed they often had significant levels of dis-
ability over prolonged periods related to the ongoing ac-
tive disease [22], as well as social dysfunction compared to
the general population [23]. This was manifested in higher
rates of unemployment, shorter timespans lived with a
partner, and decreased fertility rates [23].
Caring for children with chronic rheumatic diseases
involves a multidisciplinary approach [24]. As there is cur-
rently no cure for JIA, disease control and symptom man-
agement become of foremost importance to minimize
disability and pain [11]. The key elements to achieving op-
timal outcomes consist of early symptom detection and
diagnosis, disease stabilization, aiming for remission, and
concordance between the different treatments and inter-
ventions [25]. Stabilization of the disease involves pharma-
cological treatment to control inflammation and pain,
reduce disease progression, joint damage, disability and
loss of function, and achieve remission. Pharmacological
therapy relies on various combinations of non-steroidal
anti-inflammatory drugs, analgesics, corticosteroids, disease-
modifying anti-rheumatic drugs and biological response
modifiers such as anti-tumor necrosis factor [26-28]. Spe-
cial care should be applied to dealing with children, as
susceptibility to the toxicity of these drugs can differ
considerably between individuals and types of treatment
[27]. Individualized monitoring and management of
these drugs’ side effects is important as the type of drug
therapy can have an impact on nutrition, development,
internal organ damage, growth development and risk of
infection.
Non-pharmacological approaches aim mostly at reliev-
ing pain, decreasing stiffness, and avoiding pain recur-
rence [26]. It involves physiotherapy to help prevent
malalignment and improve function [25]. Other non-
pharmacological treatments for pain have been reviewed
by Kimura et al. [12]. They revealed that cognitive behav-
ioral therapy, physical therapy and exercise, and other ap-
proaches (massage) were promising therapies for relieving
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as well as of the multidimensional approach to pain man-
agement. Other complementary or alternative treatments
—such as hot/cold aids, transcutaneous electrical nerve
stimulation, natural medicine, and massage—have been
shown to improve comfort [25] and patients need for
more information about them [29].
The recommended assessment of patient health in
order to monitor progress of the disease includes not
only an appraisal of physical features, but also a health-
related quality-of-life measurement [30,31]. Overall as-
sessment of JIA’s disease activity consists of a core set of
measurements, including physician’s and parent/adoles-
cent’s overall assessments of disease activity, a count of
joints with arthritis and limited movement, a functional
assessment, and the erythrocyte sedimentation rate [30].
The equivalent disease-specific assessments are available
for chronic inflammatory rheumatic diseases other than
JIA [31]. Due to the potential rapid change in disease ac-
tivity, this health assessment is usually performed every
three to six months [32].
In addition to the medical visits, newly-diagnosed pa-
tients with complex needs require close monitoring, thus
follow-up is an important aspect of care for these patients
and their families. They need time to adjust to the new
diagnosis, the practicalities of the treatment, and to cope
with fears and uncertainty for the future [33]. Follow-up
monitoring of care, in which nurses play a key role, aims
to anticipate, identify and prevent problems at a clinical
level [34,35] or other psychological, emotional, and social
problems related to the disease [36].
The supporting role of nurses in the care of these
children aims to limit the potential for further disability
and psychological complications [37,38]. They play par-
ticularly key roles in supporting the specialist teams
caring for patients with rheumatic diseases, recognizing
poor disease control and the need for changes in treat-
ment, providing a resource for patients on treatment
options and how to access additional support and ad-
vice, and identifying best practices with which to
achieve optimal outcomes for patients and their fam-
ilies [25], p.48.
To fulfill their role, rheumatology nurses need to have
specific knowledge and competencies in the physical and
psychosocial evaluation of patients, the development and
implementation of treatment plans, therapeutic education,
and research utilization [34,39]. They should also have the
interpersonal skills to be able to respond to both the
child’s and the parents’ psychological and affective needs,
and help the parents cope with their child’s illness [38].
The developmental stages that children go through during
their disease is specific to pediatric rheumatology, result-
ing in the need to adapt nursing interventions to children’s
ages. For instance, nurses have to develop strategies foradolescents to cope with chronic illness that fit into their
adolescent lifestyles [40,41].
In their supporting role, nurses are also the link between
medical practitioners, other healthcare professionals, and
families; they therefore play a key role in the follow-up
care. Follow-up with children and their families can be en-
sured by regular telephone consultations made by experi-
enced, specialized rheumatology nurses. The following
paragraph introduces telenursing (TN)—a nurse-led inter-
vention adopted by many healthcare providers to increase
their efficiency in meeting patients’ needs [42].
TN includes a wide range of activities including asses-
sing patients’ needs, conducting triage in emergencies,
reassuring callers, providing nursing advice, teaching,
providing medical information, and referring patients to
appropriate care at an appropriate location [43,44]. TN
services aim to establish a relationship with the caller,
identify the concern, assess the condition, solve prob-
lems in collaboration with the caller, and select appro-
priate solutions [44]. TN has been used in different
ways, settings, and purposes. A comprehensive search of
the literature revealed numerous articles related to TN:
on triage [45-48]; state and national help lines [49-51];
follow-up of specific health conditions such as preg-
nancy [52,53]; post-operative care [54,55]; medication
adherence [56,57]; and chronic illness [58-60]. Most stud-
ies concerned adults, but some also involved pediatrics.
The following paragraph discusses TN with an emphasis
on pediatric studies involving children with chronic disease.
Follow-up calls to patients with chronic diseases, such
as asthma, heart conditions, diabetes, or cancer have been
well evaluated in adult populations [58,60,61], including
one systematic review [59]. In this latter review, nurse-led
interventions, such as telephone consultations, showed
some benefits on medication adherence by patients with
type-2 diabetes. This type of follow-up service has not
been commonly used in pediatric populations requiring
long-term follow-up of their health conditions, and this
despite the drastically increasing number of children with
chronic diseases or needing long-term care after a life-
threatening condition [62]. A literature search found only
two pediatric studies that evaluated this type of telephone
service. Gischler et al. evaluated the frequency and the
nature of the calls made by parents of children born with
severe anatomical congenital anomalies to a 24-hour tele-
phone helpline [63]. A total of 670 calls occurred outside
office hours: 24.5% calls by nurses, 20.2% led to a consult-
ation with the emergency department, resulting in 4.9%
admissions. A 24-hour helpline provides easy access to
medical information and offers supportive care to parents
at relatively low cost. This nurse-led telephone intervention
proved to be safe and efficient when back-up by a pediatric
physician was provided [63], p.625. Letourneau et al. de-
scribed the use of a TN line in a pediatric neurology clinic
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lepsy and nurses were able to solve half of the problems
without requiring further medical intervention. Although
these two studies are descriptive in nature, and thus the re-
sults should be interpreted with caution, they demonstrate
that a TN line may indeed assist in the provision of care
and support to complicated subspecialty patients.
Ensuring follow-up for children with rheumatic dis-
eases is critical for the physical and psychological well-
being of both child and family. Studies in pediatric
settings are scarce and to the best of our knowledge
nonexistent in pediatric rheumatology. Finally, the ef-
fectiveness of such a service remains to be proven in
children with chronic rheumatic diseases. In addition to
the satisfaction outcome commonly used in previous
studies, the inclusion of patient-oriented outcome mea-
sures, such as health status, would greatly add to the
value of future research in this area.
Study objectives and hypotheses
This study aims to evaluate the effect of a telenursing
intervention on the satisfaction and health outcomes of
children with inflammatory rheumatologic diseases and
their families. The primary objective is to evaluate the
effects of TN on the children/adolescent’s and parents’
satisfaction with the care given for inflammatory rheum-
atic diseases. The secondary objectives are to evaluate
the effects of TN on the child’s clinical health status, qual-
ity of life, treatment adherence, and service utilization.
Methods/Design
Study design
This study has a randomized crossover, experimental
longitudinal design, in which the intervention (telenur-
sing) is evaluated with the same subjects and so elimi-
nates between-subject variability, in particular due to the
heterogeneity of the disease [6,65]. Crossover trials are
particularly useful when the outcomes of interest are
symptoms and functional capacity [66].
Setting and participants
The setting is the pediatric rheumatology outpatient
clinic of a tertiary referral hospital in the Canton of Vaud,
which is part of the Pediatric Rheumatology Network of
Western Switzerland. Approximately 110 new patients are
admitted each year, of which about 50 present with chronic
inflammatory rheumatic diseases.
The target study population will consist of children
meeting the following criteria, plus one of their parents
(or their legal guardian).
Inclusion criteria:
 child under 16 years old at enrolment into the
study, newly diagnosed (within 18 months prior to the
enrolment date) with an inflammatory rheumatic
disease, including JIA, CTD, and vasculitis,
 registered as an outpatient with the pediatric
rheumatology clinic,
 participation of a parent (mother, father, or
guardian) in order to avoid bias (the parent will
provide the satisfaction score on behalf of the child
throughout the entire study period).
Exclusion criteria:
 children and parents who do not understand and
speak French,
 no access to a telephone.
All children who had attended the pediatric rheuma-
tology outpatient clinic from January 2010 to August
2012 were screened for eligibility in the study.
Intervention
The telenursing intervention is based on Cox’s Inter-
action Model of Client Health Behavior (IMCHB) [67].
This model offers support in determining the optimal
way for a nurse to interrelate with a patient to reach posi-
tive health outcomes. Its three conceptual foundations
are: client singularity (individuals’ characteristics), client-
professional interaction, and health outcomes [67,68] see
Figure 1.
The TN intervention is designed to ensure continuity
of care for children and their families through a tele-
phone service providing nursing advice to meet families’
needs for health information, affective support, and help
in decision-making [68]. The assumption underlying this
parent-nurse interaction is that patient satisfaction is more
likely when it is tailored to the unique needs of the pa-
tient/family client. The specific TN intervention is de-
signed to ensure continuity of care for children and their
families. This will be done via a telephone service provid-
ing nursing advice to meet families’ needs for: a) affective
support; b) health information; and c) assistance with
decision-making [68].
a. Affective support. This will involve the TN nurse
making a follow-up call each month. The nurse will
give the parent or adolescent time to speak and will
listen attentively to their concerns. TN will also
involve the nurse’s ability to calm any fears and meet
the participant’s needs (parent/guardian or older
children). The nurse’s ability to recognize the
participant’s concerns is a predictor of satisfaction [69].
b. Health information. The TN nurse will provide
information about the child’s health condition and
explain treatments, medication, tests and the overall
Figure 1 The Cox’s Interaction Model of Client Health Behavior (IMCHB) reproduced with permission from [68].
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important factor in satisfaction [69]. Information
that is of great interest to parents (besides medical
information) will be provided, including
psychological impact, rehabilitation facilities, and
alternative and complementary treatments [29].
c. Aid to decision-making. This important part of
patient satisfaction is central to TN [68,70]. The TN
nurse will facilitate parents’ involvement in making
decisions by informing them of how their child’s
care is progressing and presenting them with the
different options that are likely to suit their needs
and address their concerns [69,71,72].
Clinical knowledge, knowledge about the patient, ex-
perience, skills, understanding a multidisciplinary health-
care delivery system, and access to health information and
resources, are all critical elements for the success of the
telephone intervention and clients’ satisfaction [43,69,73].
Two specialist nurses, each with more than 5 years experi-
ence in adult and pediatric rheumatology, will attend a
three-day course to enhance their skills in verbal commu-
nication, strategies for questioning parents and adoles-
cents, assessing the quality of interactions, and aiding
decision-making. The telephone intervention process will
be standardized and recorded for each participant. It will
involve a comprehensive, systemic assessment of the par-
ticipant’s needs, including basic elements such as the par-
ticipant’s characteristics, the date, time, and nature of the
call, as well as a detailed description of the symptoms,
problems, or reasons for the call. Following this assess-
ment, prioritization and a plan will be developed collab-
oratively. Finally, the plan’s outcomes will be evaluated
(was advice followed?).
Participants in the experimental TN group will attend
a face-to-face medical and nursing consultation at base-
line (T0) and then receive a monthly telephone call for
12 months. The face-to-face visit involves the TN nurse
meeting with the parents and familiarizing herself withthe child’s clinical, social, and family situation. The TN
nurse will call the participant a total of 12 times, once
during the last week of each month. Furthermore, the
parent (and/or child if mature enough) will be given a
telephone number (except for the control group) to call,
as and when necessary, during normal Monday to Friday
office hours. The TN nurse on duty will answer these
calls and provide the same service.
Control group
Children in the control group will receive the same stand-
ard care and services provided to all children and their
families admitted to the rheumatology outpatient clinic.
Children with rheumatic diseases attend several appoint-
ments here and are followed up at varying time intervals
depending on the progress of their disease, but usually
four times a year. Currently, the medical management of
these children is provided mainly by a pediatric rheuma-
tologist, but other specialists participate as determined by
the child’s needs. Physiotherapists and occupational thera-
pists are available and can refer patients to healthcare pro-
fessionals outside the hospital.
At T0, control group participants will also have a face-
to-face medical consultation at the pediatric rheumatology
outpatient clinic, during which the study protocol will be
clarified. The medical consultation will be repeated every
three months as per current practice. Parents will be
informed that they can call the outpatient clinic when ne-
cessary and speak a duty nurse. To avoid potential con-
tamination between groups, control group parents will be
assigned a telephone number other than the TN service
number. Currently, duty nurses are clinical specialists in
pediatrics with some rheumatology experience, but are
not specifically trained in TN. The nature and frequency
of all calls will be recorded in a logbook.
Data collection
Data will be collected at different time points over the
24-month study period (see Figure 2). Participants switch
Figure 2 Telenursing intervention and data collection.
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of study period 1. In this particular study, a wash-out
period is considered unnecessary as the next measure-
ment of satisfaction takes place six months after the start
of period 2; this provides sufficient time to eliminate any
residual effects of the treatment allocated in period 1. Data
collection will be shared between the telephone nurses, a
research assistant (nurse), and a physician. Telephone
nurses will record the frequency, duration, and nature of
all calls made and received. Records of each telephone call
will be taken throughout data collection periods 1 and 2
(two years for each participant).The choice of the number
of data collection points and the study timespan is based
on theoretical and practical considerations [74]. For prac-
tical reasons, patients will be enrolled in the first week of
the month; face-to-face consultation baseline data (demo-
graphics, health status, and satisfaction) will be collected
at this time (T0). Collection points occur every three
months for assessments of disease activity and health sta-
tus (T3, T6, T9, T12, T15, T18, T21, and T24) and every
six months for the satisfaction questionnaire (T6, T12,
T18, and T24).
The qualitative data concerning satisfaction are col-
lected through interviews at the end of period 1, at T12,
and at the end of period, 2 at T24. Interviews will
be conducted by an experienced research nurse in a
non-judgmental and respectful manner, and at a pre-
determined location where privacy can be ensured. An
interview guide with specific, prompting questions has
been developed to guide the interviews. These questions
are in relation to how parents felt supported through
the service they received. Each interview will be taperecorded so as to accurately capture the participants’ com-
ments and will transcribed verbatim using standardized
transcription.
Study protocol compliance monitoring
The importance of compliance with the study will be
emphasized when participants are recruited and period-
ically during the intervention period [75]. Parental and
child compliance with their monthly telephone contacts
and their scheduled visits to the outpatient clinic will be
carefully monitored throughout the course of the study.
Intervention group participants will be considered to
have complied with the study protocol if at least 80% of
scheduled TN calls have occurred. If non-compliance is
noted, information will be gathered on underlying prob-
lems; the TN nurse will meet with a member of the re-
search team and measures will be undertaken to rectify
the situation. The same procedure will be used with par-
ticipants who repeatedly fail to attend their appointments.
Newly diagnosed children may require more frequent
medical consultations to monitor therapeutic and side
effects. All consultations between scheduled study visits,
as well as changes in treatment, will be recorded.
Primary outcome measure
The study’s primary outcome is participant satisfaction
(parent or adolescent). Cox’s IMCHB defines the concept
of satisfaction with nursing care from the patient’s per-
spective. The degree to which nurses adapt their care to
meet the specific needs of the parent, guardian, or child
relates directly to satisfaction [68]. Satisfaction is assessed
using a mixed methods approach where both quantitative
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and then the different results are converged.
Client Satisfaction Questionnaire-8 (CSQ-8) is an 8-
item version of the 18-item CSQ developed by Attkisson
and Zwick [76]. It was designed to measure global client
satisfaction in service delivery and program evaluation; it
is brief to administer, has good psychometric properties
(as demonstrated in several studies), and has been trans-
lated and validated in several languages, including French
[77]. CSQ-8’s items are rated on a 4-point Likert-type
scale giving a total score ranging between 8 (no satisfac-
tion) and 32 (total satisfaction). This study’s primary quan-
titative comparison will be the proportion of subjects in
the intervention group (TN) and the control group (stand-
ard practice) with total CSQ-8 scores ≥ 30, as well as com-
parison within subjects as measured by CSQ-8 at T0, T6,
T12, T18, and T24.
Qualitative data will be collected via individualized
semi-structured interviews (SSI) at the end of each
study period (T12 and T24) to avoid any bias. SSI have
been commonly used in evaluating health programs and
are particularly useful for exploring people’s in-depth
knowledge, experiences and understanding. They can
supplement or substantiate other sources of data [78].
Here, the objective of SSI will be to determine satisfac-
tion with regards to affective support, health informa-
tion, and support in decision-making received.
Secondary outcomes measures
Measurement of the Clinical health status will be per-
formed every three months as per standard practice.
This will consist of a core set of standardized clinical as-
sessments of disease activity and disease-specific quality-
of-life measures. Disease activity will be measured using
a core set of four measures using the standard, self-
administered, disease-specific Juvenile Arthritis Disease
Activity Score (JADAS). This includes: 1) a physician’s
overall assessment of disease activity; 2) a patient/parent
overall assessment of well-being (both measured using a
10 cm visual analogue scale); 3) the number of joints
with active disease, and; 4) the erythrocyte sedimenta-
tion rate [79]. The equivalent available disease-specific
core set of measures will be used for conditions other
than JIA [31].
Quality of life will be measured using the French version
of the Juvenile Arthritis Multidimensional Assessment Re-
port (JAMAR) for parents (JAMAR-P) and for children
aged between 11 and 18 years old (JAMAR-C). Both ori-
ginal versions of the JAMAR have been validated [80,81]
and translated using standardized translation methods
[82]. The JAMAR includes 15 patient-related outcomes:
1) a 15-item functional status questionnaire; 2) pain inten-
sity; 3) a 10-item disease-specific quality-of-life outcome,
including the physical and psychological domains; 4)child’s overall wellbeing; 5) presence of pain in joints;
6) morning stiffness; 7) presence of extra-articular
symptoms (fever and rash); 8) perception of disease activ-
ity; 9) disease status at the time of visit; 10) evolution of
the disease since previous visit; 11) list of medications
taken; 12) medication side effects; 13) difficulties with
medication administration; 14) school problems; 15) satis-
faction with the illness outcome [83].
Adherence to treatment will be measured using the
Parent Adherence Report Questionnaire (PARQ) and the
Child Adherence Report Questionnaire (CARQ) that
have both been validated in English and French [84,85].
The PARQ has been adapted to the local context with
permission of the developers and includes four questions
related to medication and exercise. Questions address
perceived difficulties in following the various forms of
treatment as well as the benefits of treatment. Each ques-
tion is rated on a 10 cm visual analogue scale. The CARQ
was developed from the PARQ to allow children ≥ 9 years
old to respond to the questions themselves [85].
Telenursing service utilization will be recorded in terms
of number, time, and duration of calls, who made them,
the nature of the call, decisions taken, descriptions of the
plan of action.
Other outcomes. Demographic data about participants
in TN and other calls will be recorded, including age,
gender, cultural background, marital status, occupa-
tion, education, language spoken at home, and types of
treatment.Sample size and power
In 2008, 113 newly diagnosed children were admitted to
the study hospital’s pediatric rheumatology outpatient
clinic. Of these, 48 were diagnosed with an inflammatory
rheumatic diseases. Based on these numbers, it is antici-
pated that around 70 children will be admitted to the
clinic in the 18-month screening period prior to enrol-
ment into the study. If we consider that 80% of patients/
parents will give consent to their participation, this
would leave a pool of 56 families available for the two-
year study period.
A power analysis was calculated based on the number
of participants expected to complete the study, not the
number recruited initially. If we consider a difference
in the proportion of subjects in the two groups with a
satisfaction score ≥30, e.g. 70% in TN versus 20% in the
control group, then 23 subjects per group (total of 46
subjects) would be required to reach a power level of
.90 for an alpha level of .05 (two-sided test). Effective
strategies will be used to maintain the sample size.
To compensate for an expected attrition rate of 20%,
two groups of 28 subjects will be recruited (total of
56 subjects).
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In crossover trials, both experimental and control experi-
ments are given to every participant, randomizing the order
in which they are applied [65]. Consenting participants will
be allocated treatment using a computer-generated simple
block randomization. The benefits of using blocks are to
ensure that the accrual of participants to either arm is uni-
form over time. An independent researcher, not involved
in the recruitment or evaluation of follow-up, will prepare
sealed, numbered envelopes containing an allocated treat-
ment. Once randomization has occurred, blinding of par-
ticipants and the caregiver is not feasible for this type of
intervention, providing a potential risk for bias.Data analysis
The equivalence of the two groups will be checked using
demographic variables such as age, marital status, occu-
pation, level of education, cultural background, language,
and child’s diagnosis. Differences between groups will be
tested using chi-square and t-tests.Hypotheses testing
We will carry out an ‘intent to treat’ analysis. That is,
participants will remain in the group to which they were
allocated or assigned, whether or not they are poor com-
pliers with the TN intervention. Data will be summa-
rized with the mean and SD; continuous variables will
be tested for normality.
Data will be analyzed using mixed effect linear models
to exclude any ‘carry-over’ and ‘temporal’ effect of the
treatment and to test the time effect of TN. Data ana-
lyses will be performed a statistician using Stata version
13 software.Statistical methods
Mixed methods analyses
The primary outcome of satisfaction, as measured using
the CSQ and the interviews, will be analyzed using the
triangulation design convergence model described by
Creswell [86]. This model is used for comparing results
and corroborate quantitative results with qualitative
findings. The quantitative and qualitative data will be
analyzed separately, but the different results will be
converged (by comparing and contrasting the results)
for the interpretation of the findings. This method will
provide valid and substantiated conclusions about the
satisfaction outcome. Qualitative data analyses will be
carried out using the content analysis method, includ-
ing, a) identification of units of analysis, and b) analysis
of content by developing categories using ATLAS.ti V6
computer software [87].Data screening and missing data
Prior to data analyses, data will be screened for the accur-
acy of the data file, missing data, outliers, and distribution.
Cases with more than 20% of missing data will be excluded
from analyses and missing data will be randomly replaced
using the expectation maximization (EM) method. “EM
forms a missing data correlation matrix by assuming the
shape of a distribution…for the partially missing data and
basing inferences about missing values on the likelihood
under that distribution” (p. 63) [88]. Normally distributed
data and homogeneity of variance will be analyzed using
parametric tests, and skewed data will be analyzed with
the equivalent non-parametric tests.
Representativeness and bias
Demographic data and reasons for refusals to participate
in the study, as well as those who are lost (withdraw, lost
to follow-up, etc.…), will be compared to participants
who remain in the study. Recruitment will be performed
at the tertiary referral hospital for children with chronic
rheumatic diseases in the Canton of Vaud, which will
ensure the representativeness of the population of chil-
dren with this condition and avoid referral bias. Further-
more, strategies to maximize the follow-up of study
participants from both groups will be used. Finally, to
minimize the risk for bias in self-reported satisfaction,
participants will return their completed questionnaires
in sealed envelopes addressed to the research team. Par-
ticipants will also be informed that their satisfaction
levels will be confidential, will not be shared with their
caregivers, and will not interfere with the quantity and
quality of care provided.
Natural maturation
will take place as each participant (adolescent and/or par-
ent) becomes more familiar with the disease and treat-
ment, which can potentially result in better satisfaction
scores and outcomes. This aspect is dealt with in two
ways. First, the crossover design with a randomized as-
signment of participants should decrease the risk of bias
in the selection groups and result in similar distributions
in each group. The adequacy of the follow-up durations
for this study was determined in previous studies [14,74].
Contamination
Is not expected as each TN consultation is done on an
individual basis. However, if contamination where to
occur, this would result in better outcomes in the con-
trol group and would consequently reveal an apparent
null effect of the intervention. We do not expect the
usual high standards of care and services to change as a
result of the introduction of TN as the nurse who gives
the TN consultation is self-employed and provides the ser-
vice on a private individual basis. Furthermore, a mobile
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ferent from the outpatient clinic’s number assigned to
the control group. To further control risk of contamin-
ation, only newly diagnosed children will be recruited
into the study; they will thus not have had the oppor-
tunity to develop any relationships with the staff currently
working at the study site. Nevertheless, all changes in pol-
icies and documentation will be recorded during the study
period.Data management
Data quality
To ensure data quality, the research assistant will verify
that all research forms have been completed at each data
collection point of each data collection period. However, it
is ultimately the Principal Investigator’s responsibility to
ensure that appropriate work books and data sheets con-
tain accurate and complete information.Confidentiality and data security
Access to medical records will be limited to the research
team and only with the approval of the Medical Director
of the outpatient clinic. Measures to ensure data security
and participant confidentiality will include: the removal
of all identifying data and coding on the research forms;
the storage of coded data on a password-protected com-
puter with personal logins; access to data being limited
exclusively to the research team; and data stored on
paper or in recorded forms will be securely stored in a
locked cabinet in the Principal Investigator’s office for a
duration of 10 years after completion of the study [89].Ethical considerations
The study and its amendment were approved by the
Human Research Ethics Committee on January 17, 2011
and March 28, 2011, respectively.
Families who met the inclusion criteria received an in-
formation letter by post about the research study and were
informed that it will be discussed at their next appoint-
ment with the medical specialist. They received verbal in-
formation about the study’s objectives, its procedures,
potential risks, and their right not to participate or to
withdraw at any time without this affecting the quality of
future care. They were also informed of the measures
taken by the researcher to ensure confidentiality, including
that the participants will not be individually identified by
name in reports or publications. Upon agreement to par-
ticipation in the study, parents will be asked to provide
written informed consent. Written assent will be obtained
from children who are considered to have the capacity to
make an ‘informed decision’ about the intervention (from
11 to 16 years).Discussion
The literature review highlighted the paucity of studies
demonstrating strong evidence of the benefits of TN
consultations for children with chronic conditions. How-
ever, nurse-led telephone follow-up interventions have
shown positive effects on treatment adherence in adult
populations with chronic illness [90]. Treatment adher-
ence to control children’s rheumatic diseases is crucial
to limiting disability later in life. However, we know
from the literature that when children enter adolescence,
treatment adherence is poor, which may result in detri-
mental consequences [91]. Support to parents and ado-
lescents is crucial in this difficult transition phase. Our
intervention was designed to provide information, affective
support, and aid to decision-making. Although this inter-
vention has been standardized, it allows for individualized
care because it is tailored to the client’s characteristics and
needs ensuring regular follow-up care. The intervention is
very much dependent on the competence of the person
providing the consultation. It is clear that this type of
interaction requires advanced specialized skills, which is
the case with the nurses involved in our TN study.
This study’s design has several strengths. First, the
combination of quantitative and qualitative data for the
primary outcome (satisfaction) will provide a better under-
standing of how and why the participants are satisfied with
the service and will provide additional validity to the re-
sults. Second, the study is conducted in several centers,
representing a large proportion of the population of inter-
est in western Switzerland. Third, the processes put in
place for the quality control of study protocol compliance
should be highlighted. All telephone calls are recorded and
a checklist ensures that all elements of the intervention are
provided. Close study monitoring also provides important
information about the feasibility of the study intervention
in real life situations. Finally, the research is an attempt to
meet the needs of the population of children and adoles-
cents with rheumatic diseases in western Switzerland. This
topic is of foremost importance because, health outcomes
have become a priority for hospital-wide quality improve-
ment initiatives and the Swiss Nursing Research Agenda.
Some limitations must be acknowledged, however.
The intervention made by two experienced nurses may
be difficult to replicate by others if the necessary training
and formal education is not provided to nurses. To the
best of our knowledge, this type of education is not of-
fered in current postgraduate nursing programs. Finally,
the JAMAR questionnaires have been validated in their
original versions only. Psychometric equivalence has yet
to be determined and the results of this study will con-
tribute to the further psychometric testing of this ques-
tionnaire. However, the rigorous translation method and
pre-test should have minimized the risk of a change in
the psychometric properties of the questionnaires.
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Recruitment for the trial started in August 2011 and
follow-up data collection is due to complete in August
2014.
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